Investing.com - Clene reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Clene announced earnings per share of $-0.17 on revenue of $174K. Analysts polled by Investing.com anticipated EPS of $-0.20 on revenue of $83.33K.
Clene shares are down 32% from the beginning of the year, still down 84.48% from its 52 week high of $6.12 set on December 1, 2021.
Clene shares lost 14.18% in intra-day trade following the report.
Clene follows other major Healthcare sector earnings this month
Clene's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar